WO2023079137 - NEUTRALIZING ANTI-SARS-COV-2 HUMAN ANTIBODIES
National phase entry is expected:
Publication Number
WO/2023/079137
Publication Date
11.05.2023
International Application No.
PCT/EP2022/080965
International Filing Date
07.11.2022
Title **
[English]
NEUTRALIZING ANTI-SARS-COV-2 HUMAN ANTIBODIES
[French]
ANTICORPS HUMAINS NEUTRALISANT ANTI-SARS-COV-2
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
VIB VZW
UNIVERSITEIT GENT
Inventors
GEUKENS, Nick
DECLERCK, Paul
IMBRECHTS, Maya
AMPOFO, Louanne
MAES, Wim
NEYTS, Johan
ABDELNABI, Rana
EECKHAUT, Hannah
CALLEWAERT, Nico
FIJALKOWSKA, Daria
Priority Data
21206787.0
05.11.2021
EP
21216594.8
21.12.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2499 | |
| EPO | Filing, Examination, Granting | 9820 | |
| Japan | Filing, Examination, Granting | 2183 | |
| South Korea | Filing, Examination, Granting | 2052 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,294
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
of less than 300 pM.[French]
inférieur à 300 pM.